525 patents currently held
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
99
Ending by 2030
Dec 2026
Next term end
348
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2033 · High confidence
Also notable
Ends May 2033 · High confidence
Also notable
Ends Apr 2039 · High confidence
Also notable
Ends no later than Oct 2032 · Medium confidence
Also notable
Ends Jan 2033 · High confidence
Also notable
Ends no later than Sep 2029 · Medium confidence
Also notable
Ends Dec 2032 · High confidence
Also notable
Ends Nov 2032 · High confidence
Contact Lenses Comprising Water Soluble N-2 Hydroxyalkyl) (METH)ACRYLAMIDE Polymers or Copolymers
US 9,297,929
Cited by 102 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Polymers and Nanogel Materials and Methods for Making and Using the Same
US 9,244,196
Cited by 98 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Polymerizable Absorbers of Uv and High Energy Visible Light
US 10,935,695
Cited by 22 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
Medical Devices Having Homogeneous Charge Density and Methods for Making Same
US 9,170,349
Cited by 97 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Variable Focus Ophthalmic Device Including Liquid Crystal Elements
US 8,906,088
The most cited patent in this portfolio, cited by 166 later US patents, top 5% of utility patents granted in 2014 in our data. Protection runs to 2033.
Ionic Silicone Hydrogels Having Improved Hydrolytic Stability
US 9,260,544
Cited by 72 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Ionic Silicone Hydrogels
US 9,125,808
Cited by 91 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
Full Rings for a Functionalized Layer Insert of an Ophthalmic Lens
US 9,195,075
Cited by 65 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 26 to 28, 2026 · next Nov 26
- 11 fees due Dec 9 to 30, 2026 · next Dec 9
- 10 fees due Jan 7 to 28, 2027 · next Jan 7
- 19 fees due Feb 6 to 28, 2027 · next Feb 6
- 10 fees due Mar 3 to 26, 2027 · next Mar 3
- 18 fees due Apr 3 to 29, 2027 · next Apr 3
- 14 fees due May 3 to 28, 2027 · next May 3
- 10 fees due Jun 3 to 30, 2027 · next Jun 3
- 7 fees due Jul 2 to 30, 2027 · next Jul 2
- 9 fees due Aug 4 to 27, 2027 · next Aug 4
- 6 fees due Sep 15 to 30, 2027 · next Sep 15
- 12 fees due Oct 2 to 30, 2027 · next Oct 2
- 4 fees due Nov 3 to 14, 2027 · next Nov 3
Recent changes
- 8 of the patents on this record were granted since Aug 23, 2026
- 16 terms have ended since Aug 23, 2026
- Nov 20 US 9,056,880 Process for Producing Hydrolysis-Resistant Silicone Compounds · term ended
- Nov 20 US 9,056,878 Hydrolysis-Resistant Silicone Compounds · term ended
- Nov 20 US 8,921,449 Hydrolysis-Resistant Silicone Compounds · term ended
- Nov 20 US 8,779,178 Hydrolysis-Resistant Silicone Compounds · term ended
- Nov 20 US 8,357,818 Hydrolysis-Resistant Silicone Compounds · term ended
- Nov 10 US 10,197,707 Ophthalmic Devices Comprising Photochromic Materials with Reactive Substituents · term ended
- Oct 21 US 8,867,141 Lens with Multi-Concave Meniscus Wall · lapsed on the fee record
- Oct 19 US 7,988,289 Ophthalmic Lenses Useful for the Correction of Presbyopia Which Incorporate High Order Aberration Correction · term ended
- Oct 18 US 7,431,454 Methods for Designing Tinted Contact Lenses · term ended
- Oct 16 US 10,101,581 Electronic Ophthalmic Lens with Eye Closed Sensor with Open Eye Prompt and Data Logging · lapsed on the fee record
- Sep 19 US 11,256,002 Ophthalmic Devices Comprising Photochromic Materials with Reactive Substituents · term ended
- Sep 11 US 10,073,192 Polymers and Nanogel Materials and Methods for Making and Using the Same · lapsed on the fee record
- Sep 7 US 7,503,652 Translating Multifocal Ophthalmic Lenses · term ended
- Sep 2 US 8,821,457 Punctal Plug Containing Drug Formulation · lapsed on the fee record
- Sep 2 US 8,820,924 Inversion Marking for Contact Lenses · lapsed on the fee record
What they patent
The largest of its 348 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,517,084 | Multifocal Contact Lens Designs Utilizing Pupil Apodization In force · High confidence | In force | High confidence | |
| US 10,045,975 | Methods and Ophthalmic Devices Used in the Treatment of Ocular Allergies In force · High confidence | In force | High confidence | |
| US 10,617,695 | Ophthalmic Compositions Containing Alcaftadine In force · Medium confidence | In force | Medium confidence | |
| US 7,784,608 | Contact Lens Packages In force · High confidence | In force | High confidence | |
| US 7,832,860 | Tinted Contact Lenses Having a Depth Effect In force · High confidence | In force | High confidence | |
| US 7,481,533 | Method for Designing Multifocal Contact Lenses In force · High confidence | In force | High confidence | |
| US 8,080,622 | Soluble Silicone Prepolymers In force · High confidence | In force | High confidence | |
| US 8,399,539 | Soluble Silicone Prepolymers In force · High confidence | In force | High confidence | |
| US 9,162,401 | Devices and Processes for Performing Degassing Operations In force · High confidence | In force | High confidence | |
| US 8,569,538 | Acryloyl Materials for Molded Plastics In force · High confidence | In force | High confidence |
Also on record, not counted in the 525: 14 patents in force now held by others · 317 patents ended · 64 applications pending · 363 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.